News-Medical.Net Gene Therapy News
- Home
- Breaking News
- Patient Information
- Conferences
- Publications
- Viral Vectors
- Clinical Trials
- Books
- Jobs
- Quiz
Login
Related Links
Special News Items
- NVGCT launches new website
- Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation And Requests Further Information From the CHMP
- HSCI Receives Approval To Market Neovasculgen – The First Russian Gene Therapy Drug For Treatment Of Peripheral Arterial Disease
- Gene therapy proves effective for hemophilia B
- Cell Line Development & Engineering Asia 2012
- Gene Therapy Video on the CliniGene Website
- AMT Suspends Glybera and Plans 50% Job Cuts in Restructuring Moves
- Amsterdam Molecular Therapeutics Receives Opinion on Re-examination of Glybera® Marketing Authorisation Application
- Gene therapy and stem cells unite
- Gene Therapists Celebrate a Decade of Progress
- Sangamo gene therapy shows promise in reducing HIV
- Bubble Boys Treated With Gene Therapy Still Healthy After 9 Years
- Genetically modified cells destroy leukaemia tumours
- Evolution: A View from the 20th Century
- Survey on Risk Assessment in Clinical Trials
- Amsterdam Molecular Therapeutics Receives Opinion on Glybera Marketing Authorisation Application
- New approach to cancer vaccines proves successful in early studies
- A new start for gene therapy for “bubble boy” disease: First U.S.-treated patient doing well
- Monkey Vaccine Has Promise For Eventual Human HIV Vaccine
- Gene Therapy Will be a Vital Part of Future Health Care
- Moving gene therapy into high gear
- First Clinical Trial of Gene Therapy for Pain Shows Substantial Pain Relief for Patients
- EU Clinical Trials Register goes live
- Gene therapy a reality for Parkinson's
- NVGT Embraces Cell Therapy with Name Change
- Zinc finger gene therapy produces HIV-resistant CD4 T-cells
- New Anti-HIV Gene Therapy Makes T-Cells Resistant to HIV Infection
- Gene therapy to fix memory loss in Alzheimer's patients study
- The Use of Gene Therapy in Treating Retinitis Pigmentosa and Dry Age-related Macular Degeneration (AMD)
- NIH RAC and CliniGene Co-host a Scientific Symposium on 'Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design'
| © 2012 Gene Therapy Net. Contact Us | Privacy Policy | About Us | Sitemap | Bookmark | Homepage | Link to Gene Therapy Net | ^ Back to Top |
